The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...
The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...
The landmark SIRFLOX trial, a...